Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-13

FDA Approved: IWILFIN — Original Application (USWM, LLC)

View source ↗

Summary

The FDA approved IWILFIN (eflornithine hydrochloride) under an original NDA from USWM, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IWILFIN (Eflornithine hydrochloride)

Snippet

ORIG AP for IWILFIN (EFLORNITHINE HYDROCHLORIDE)